StonvexLoading…
StonvexStonvexStonvexCore line items from MYRG's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
Quarterly filings sourced directly from SEC EDGAR. Real-time earnings actuals are in the Earnings panel above.
| Metric | Annual 2025 2025-12-31 | Annual 2024 2024-12-31 | Annual 2023 2023-12-31 | Annual 2022 2022-12-31 |
|---|---|---|---|---|
Revenue | $3.66B | $3.36B | $3.64B | $3.01B |
Operating Income | $166.87M | $54.08M | $129.09M | $114.91M |
Net Income | $118.42M | $30.26M | $90.99M | $83.38M |
EPS (Diluted) | $7.53 | $1.83 | $5.40 | $4.91 |
Total Assets | $1.64B | $1.49B | $1.58B | $1.40B |
Total Liabilities | $983.66M | $888.44M | $927.54M | $838.66M |
Cash & Equivalents | $150.16M | $3.46M | $24.90M | $51.04M |
Free Cash Flow OCF − CapEx | $232.19M | $11.18M | $-13.72M | $90.43M |
Shares Outstanding | 15.52M | 16.12M | 16.68M | 16.56M |